NIH-funded research R01 grant

Investigating the role of FOXO4 in brain injury from ischemic stroke

Official title: FOXOs in ischemic stroke

Funded at Texas Tech University Health Scis Center · NIH-11145268 · Data updated 2026-11-12

This study is looking at how a gene called FOXO4 affects brain injuries from strokes, and it hopes to find ways to reduce damage and improve recovery for people who have had a stroke or are at risk for Alzheimer's disease.

More Stroke research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Tech University Health Scis Center
NIH-funded
Lab location1 site (Lubbock, United States)
Project startMay 1, 2024
Project endApril 30, 2027
Funding year2025
Award (this year)$382,500
NIH project number5R01NS124846-04
Project IDNIH-11145268 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have suffered an ischemic stroke or are at risk of developing Alzheimer's disease.

Less likely to help

Patients with non-ischemic stroke conditions or those who do not have any neurodegenerative diseases may not benefit from this research.

What this research studies

This research focuses on understanding how the FOXO4 gene influences brain injury caused by ischemic stroke. The study aims to explore the relationship between FOXO4 and neuroinflammation, mitochondrial dysfunction, and oxidative stress, which are critical factors in brain damage and the development of Alzheimer's disease-like symptoms. By using a mouse model, researchers will assess the effects of inhibiting FOXO4 to determine if it can reduce brain injury and improve recovery outcomes. The ultimate goal is to identify new therapeutic targets that could lead to better treatments for patients suffering from ischemic stroke and related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve recovery and outcomes for patients who have experienced an ischemic stroke.

How similar studies have gone: Previous research has shown promising results in targeting FOXO4 for neuroprotection, suggesting that this approach may lead to significant advancements in treatment.

Where this research is happening

  • Texas Tech University Health Scis Center
    Lubbock, United States
    Active

Researchers

  • Principal investigator: Wang, Hongmin — Texas Tech University Health Scis Center
  • Study coordinator: Wang, Hongmin

Related research

Other NIH-funded projects on the same topics.

  • Improving blood flow after stroke by breaking down NETs

    Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11606640

  • EP2 blockers to protect the brain after a stroke

    Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.

    NIH research University of Tennessee Health Sci Ctr · Memphis, United States · NIH-11548335

  • Genetic testing to find causes of early-onset ischemic stroke

    This project uses whole-exome sequencing to look for gene changes that may cause ischemic stroke in adults who had a stroke at a young age.

    NIH research Baltimore VA Medical Center · Baltimore, United States · NIH-11510007

  • Targeted nanomedicine to protect the brain after stroke

    A targeted drug-delivery approach aims to boost blood-brain barrier repair and reduce brain damage after an acute ischemic stroke in patients at risk.

    NIH research Temple Univ of the Commonwealth · Philadelphia, United States · NIH-11504265

  • How biological aging and blood proteins relate to thinking after a stroke

    This project looks at whether measures of biological aging and patterns of blood proteins help explain which stroke survivors keep their thinking sharp and which go on to develop vascular dementia.

    NIH research University of Florida · Gainesville, United States · NIH-11470695

  • Repurposing NEXLETOL to treat ischemic stroke

    Aims to see if the cholesterol drug NEXLETOL can help people after an ischemic stroke by supporting brain energy use and reducing injury.

    NIH research Tulane University of Louisiana · New Orleans, United States · NIH-11468414

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.